Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1997-01-10
1999-09-21
Teska, Kevin J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514557, 514 4, 600483, 600301, 600300, 607 18, G06G 748
Patent
active
059565012
ABSTRACT:
A system and method for predicting the effect of patient self-care actions on a disease control parameter. A future disease control parameter value X(t.sub.j) at time t.sub.j is determined from a prior disease control parameter value X(t.sub.i) at time t.sub.i based on an optimal control parameter value R(t.sub.j) at time t.sub.j, the difference between the prior disease control parameter value X(t.sub.i) and an optimal control parameter value R(t.sub.i) at time t.sub.i, and a set of differentials between patient self-care parameters having patient self-care values S.sub.M (t.sub.i) at time t.sub.i and optimal self-care parameters having optimal self-care values O.sub.M (t.sub.i) at time t.sub.i. The differentials are multiplied by corresponding scaling factors K.sub.M. The system includes an input device for entering the patient self-care values S.sub.M (t.sub.i). A memory stores the optimal control parameter values R(t.sub.i) and R(t.sub.j), the prior disease control parameter value X(t.sub.i), the optimal self-care values O.sub.M (t.sub.i), and the scaling factors K.sub.M. A processor in communication with the input device and memory calculates the future disease control parameter value X(t.sub.j). A display is connected to the processor to display the future disease control parameter value X(t.sub.j) to a patient.
REFERENCES:
patent: 5321009 (1994-06-01), Baeder et al.
patent: 5325288 (1994-06-01), Satou
patent: 5431690 (1995-07-01), Schaldach et al.
patent: 5680866 (1997-10-01), Kangas et al.
patent: 5710178 (1998-01-01), Samid
Patient-Specific explanation in models of chronic disease. By Holy B. Jimison, L. M. Fagan, R. D. Shachter and E. H. Shortliffe. Revised Feb. 1992 Artificial Intelligence in Medicine 4 (1992) 191-205.
Health Hero Network, Inc.
Irshadullah M.
Teska Kevin J.
LandOfFree
Disease simulation system and method does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Disease simulation system and method, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Disease simulation system and method will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-89404